The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Baltimore, Maryland, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases | Neoplasms by Site, Skin and Connective Tissue Diseases, brain disorder, breast disorder, breast neoplasm, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder, skin disorder | Recruiting | Phase 2 | 2026-08-21 | NCT06764940 |